• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减肥意愿和虚弱与肾移植术前结果相关。

Weight Loss Intentionality and Frailty are Associated with Pre-Kidney Transplant Outcomes.

作者信息

Ghildayal Nidhi, Hong Jingyao, Liu Yi, Li Yiting, Cockey Samuel G, Ali Nicole M, Mathur Aarti, Orandi Babak, Segev Dorry L, McAdams-DeMarco Mara

机构信息

Department of Surgery, NYU Grossman School of Medicine and NYU Langone Health, New York, New York.

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

Clin J Am Soc Nephrol. 2025 Jan 3;20(2):197-205. doi: 10.2215/CJN.0000000604.

DOI:10.2215/CJN.0000000604
PMID:39621583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11835156/
Abstract

KEY POINTS

In frail kidney transplant (KT) candidates with obesity, unintentional weight loss preceding KT evaluation is associated with lower chance of listing. In frail candidates with obesity, both unintentional and intentional weight loss is associated with higher waitlist mortality. Results suggest that in frail candidates with obesity, careful supervision of weight loss prior to KT should be considered, emphasizing strategies to preserve muscle mass and function.

BACKGROUND

Unintentional weight loss, a hallmark of frailty, predicts worse post–kidney transplantation (KT) outcomes. However, weight loss in candidates with obesity is often recommended to enhance transplant eligibility. We tested whether pre-evaluation weight change is associated with listing/waitlist mortality, considering intentionality and frailty.

METHODS

We leveraged data on body mass index, weight loss intentionality (1 year before evaluation and at evaluation), and frailty (four-component Physical Frailty Phenotype at evaluation) for 1361 candidates (895 listed) with obesity (body mass index ≥30 kg/m) enrolled in a prospective multicenter cohort study. We estimated the association between pre-evaluation weight change (stable, gain, unintentional/intentional loss) with chance of listing/waitlist mortality using Cox proportional hazards/competing-risks models.

RESULTS

Among candidates with obesity, 48% had stable weight, 17% had weight gain, 16% had unintentional weight loss, and 20% had intentional weight loss over the year before evaluation. Among frail candidates with obesity, stable weight was associated with a 27% lower chance of listing (adjusted hazard ratio [aHR], 0.73; 95% confidence intervals [CI], 0.55 to 0.96), weight gain with a 47% lower chance of listing (aHR, 0.53; 95% CI, 0.34 to 0.80), and unintentional weight loss with a 48% lower chance of listing (aHR, 0.52; 95% CI, 0.32 to 0.84) compared with nonfrail candidates with stable weight. However, in frail candidates with obesity, intentional weight loss was not associated with a significantly lower chance of listing compared with nonfrail candidates with stable weight. In addition, among frail candidates with obesity, stable weight (adjusted subhazard ratio [aSHR], 1.72; 95% CI, 1.01 to 2.90), unintentional weight loss (aSHR, 2.78; 95% CI, 1.23 to 6.27), and intentional weight loss (aSHR, 2.26; 95% CI, 1.05 to 4.85) were associated with higher waitlist mortality compared with nonfrail candidates with stable weight. Among nonfrail candidates, no associations were observed for weight change and frailty status with either chance of listing or waitlist mortality.

CONCLUSIONS

Among frail candidates with obesity, unintentional pre-KT weight loss is associated with a lower chance of listing; however, any weight loss is associated with higher waitlist mortality. Our findings suggest that frail candidates with obesity may benefit from clinician supervision of pre-KT weight loss.

摘要

要点

在肥胖的体弱肾移植(KT)候选者中,KT评估前的非故意体重减轻与列入等待名单的可能性较低有关。在肥胖的体弱候选者中,非故意和故意体重减轻均与等待名单死亡率较高有关。结果表明,对于肥胖的体弱候选者,应考虑在KT前对体重减轻进行仔细监督,强调保留肌肉质量和功能的策略。

背景

非故意体重减轻是体弱的一个标志,预示着肾移植(KT)后更差的结果。然而,肥胖候选者的体重减轻通常被推荐以提高移植资格。我们测试了评估前体重变化是否与列入等待名单/等待名单死亡率相关,同时考虑了意向性和体弱情况。

方法

我们利用了一项前瞻性多中心队列研究中1361名肥胖(体重指数≥30kg/m)候选者(895名已列入等待名单)的体重指数、体重减轻意向性(评估前1年和评估时)以及体弱情况(评估时的四成分身体虚弱表型)的数据。我们使用Cox比例风险/竞争风险模型估计评估前体重变化(稳定、增加、非故意/故意减轻)与列入等待名单/等待名单死亡率之间的关联。

结果

在肥胖候选者中,48%的人体重稳定,17%的人体重增加,16%的人非故意体重减轻,20%的人故意体重减轻。在肥胖的体弱候选者中,与体重稳定的非体弱候选者相比,体重稳定与列入等待名单的可能性降低27%相关(调整后风险比[aHR],0.73;95%置信区间[CI],0.55至0.96),体重增加与列入等待名单的可能性降低47%相关(aHR,0.53;95%CI,0.34至0.80),非故意体重减轻与列入等待名单的可能性降低48%相关(aHR,0.52;95%CI,0.32至0.84)。然而,在肥胖的体弱候选者中,与体重稳定的非体弱候选者相比,故意体重减轻与列入等待名单的可能性显著降低无关。此外,在肥胖的体弱候选者中,与体重稳定的非体弱候选者相比,体重稳定(调整后亚风险比[aSHR],1.72;95%CI,1.01至2.90)、非故意体重减轻(aSHR,2.78;95%CI,1.23至6.27)和故意体重减轻(aSHR,2.26;95%CI,1.05至4.85)与等待名单死亡率较高相关。在非体弱候选者中,未观察到体重变化和体弱状态与列入等待名单或等待名单死亡率之间的关联。

结论

在肥胖的体弱候选者中,KT前的非故意体重减轻与列入等待名单的可能性较低有关;然而,任何体重减轻都与等待名单死亡率较高有关。我们的研究结果表明,肥胖的体弱候选者可能受益于临床医生对KT前体重减轻的监督。

相似文献

1
Weight Loss Intentionality and Frailty are Associated with Pre-Kidney Transplant Outcomes.减肥意愿和虚弱与肾移植术前结果相关。
Clin J Am Soc Nephrol. 2025 Jan 3;20(2):197-205. doi: 10.2215/CJN.0000000604.
2
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
3
Use of sodium-glucose co-transporter 2 inhibitors in solid organ transplant recipients with pre-existing type 2 or post-transplantation diabetes mellitus: A systematic review.钠-葡萄糖协同转运蛋白2抑制剂在患有2型糖尿病或移植后糖尿病的实体器官移植受者中的应用:一项系统评价。
Transplant Rev (Orlando). 2023 Jan;37(1):100729. doi: 10.1016/j.trre.2022.100729. Epub 2022 Nov 4.
4
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
5
Persistent versus resolved donor-specific antibodies predict 10-year antibody-mediated rejection and kidney transplant outcomes in Thailand.持续性与已消失的供体特异性抗体可预测泰国10年抗体介导的排斥反应及肾移植结局。
Sci Rep. 2025 Jul 1;15(1):21538. doi: 10.1038/s41598-025-07681-4.
6
Effect of frailty as measured by functional impairment on long-term outcomes in liver transplantation in the United States.在美国,通过功能损害衡量的虚弱对肝移植长期预后的影响。
World J Transplant. 2025 Jun 18;15(2):98228. doi: 10.5500/wjt.v15.i2.98228.
7
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
8
Interventions for BK virus infection in kidney transplant recipients.肾移植受者 BK 病毒感染的干预措施。
Cochrane Database Syst Rev. 2024 Oct 9;10(10):CD013344. doi: 10.1002/14651858.CD013344.pub2.
9
Evaluation of health care utilisation and mortality in medical hospitalisations with multimorbidity and kidney disease, according to frailty: a nationwide cohort study.根据衰弱状况评估患有多种疾病和肾脏疾病的住院患者的医疗保健利用和死亡率:一项全国性队列研究。
Swiss Med Wkly. 2024 Jun 22;154(6):3400. doi: 10.57187/s.3400.
10
The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes.衰弱对身体成分的影响及其对老年糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂的影响。
Metabolites. 2025 Jun 9;15(6):381. doi: 10.3390/metabo15060381.

本文引用的文献

1
Medical Distrust Among Kidney Transplant Candidates.肾移植候选者中的医疗不信任感。
Clin Transplant. 2024 Jul;38(7):e15395. doi: 10.1111/ctr.15395.
2
Antiobesity pharmacotherapy to facilitate living kidney donation.促进活体肾脏捐献的抗肥胖药物治疗。
Am J Transplant. 2024 Mar;24(3):328-337. doi: 10.1016/j.ajt.2023.12.003. Epub 2023 Dec 10.
3
Abdominal computed tomography measurements of body composition and waitlist mortality in kidney transplant candidates.腹部计算机断层扫描测量身体成分和肾移植候选者等待名单死亡率。
Am J Transplant. 2024 Apr;24(4):591-605. doi: 10.1016/j.ajt.2023.11.002. Epub 2023 Nov 8.
4
Development and Validation of an Abridged Physical Frailty Phenotype for Clinical Use: A Cohort Study Among Kidney Transplant Candidates.用于临床的简化身体虚弱表型的制定和验证:肾移植候选者队列研究。
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad173.
5
Frailty assessment as part of transplant listing: yes, no or maybe?虚弱评估作为移植登记的一部分:是、否还是待定?
Clin Kidney J. 2022 Dec 30;16(5):809-816. doi: 10.1093/ckj/sfac277. eCollection 2023 May.
6
Change in Body Mass Index and Attributable Risk of New-Onset Hypertension Among Obese Living Kidney Donors.肥胖活体供肾者体重指数变化与新发高血压的归因风险。
Ann Surg. 2023 Jul 1;278(1):e115-e122. doi: 10.1097/SLA.0000000000005669. Epub 2022 Aug 10.
7
Weight Loss Challenges in Achieving Transplant Eligibility in Patients With Kidney Failure: A Qualitative Study.肾衰竭患者达到移植资格的体重减轻挑战:一项定性研究。
Kidney Med. 2021 Nov 11;4(3):100388. doi: 10.1016/j.xkme.2021.09.005. eCollection 2022 Mar.
8
Obesity Management in Kidney Transplant Candidates: Current Paradigms and Gaps in Knowledge.肾移植候选人的肥胖管理:当前知识的范例和差距。
Adv Chronic Kidney Dis. 2021 Nov;28(6):528-541. doi: 10.1053/j.ackd.2021.09.009.
9
Long-Term Trajectories of Frailty and Its Components After Kidney Transplantation.肾移植后虚弱及其成分的长期轨迹。
J Gerontol A Biol Sci Med Sci. 2022 Dec 29;77(12):2474-2481. doi: 10.1093/gerona/glac051.
10
Revision of frailty assessment in kidney transplant recipients: Replacing unintentional weight loss with CT-assessed sarcopenia in the physical frailty phenotype.修订肾移植受者虚弱评估:用 CT 评估的肌肉减少症替代身体虚弱表型中的非有意体重减轻。
Am J Transplant. 2022 Apr;22(4):1145-1157. doi: 10.1111/ajt.16934. Epub 2022 Jan 8.